5,900 cough syrup bottles seized in Vizag

VISAKHAPATNAM: Close on the heels of the deaths of children in Madhya Pradesh and Rajasthan after they consumed adulterated cough syrup, drug inspection teams seized around 5,900 bottles of Rivicold cold and cough syrups worth ₹4.5 lakh over violation of norms in Visakhapatnam on Monday.

Drugs Inspector M. Srinivas Rao said the the cold and cough syrup bottles were seized during a raid on the premises of Kirbi Life Sciences, a wholesale medical agency at Marripalem, as the bottles did not carry the mandatory warning on their labels that ‘the syrup is not to be used for children below 4 years of age’.

These syrups contain a combination chlorpheniramine maleate and phenylephrine hydrochloride, manufactured by Bajaj Formulations in Haridwar of Uttarakhand.

“The labels do not carry the mandatory warning that the syrup is not to be used for children below 4 years of age. Due to this omission, there is a potential risk of the syrup being used for children,” Mr. M. Srinivas Rao said.

A case has been registered against the manufacturer under Section 26A of the Drugs and Cosmetics Act, and the seized syrups will be produced before the court for further orders, he said.

Citing the deaths of children in Madhya Pradesh and Rajasthan due to adulterated cough syrups, the Drugs Inspector warned that stringent legal action would be taken against any licensee selling prohibited combinations. “No cold or cough syrup for children should be sold without a valid prescription from a registered medical practitioner,” he said.

Drugs Inspector Abhipriya and a team of police personnel also participated in the raid.

The raid was conducted on the directions of P.S. Girisha, Director General, Drugs Control Administration, under the supervision of S. Vijaya Kumar, Assistant Director, DCA, Visakhapatnam.

Mr. Srinivasa Rao said stringent action would be taken against those selling such syrups without prescription.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs